The PE Ratio as of December 2024 (TTM) for Procaps Group S.A. (PROC) is 4.86

According to Procaps Group S.A.’s latest financial reports and current stock price. The company's current PE Ratio is 4.86. This represents a change of -55.94% compared to the average of 11.03 of the last 4 quarters.

Procaps Group S.A. (PROC) Historical PE Ratio (quarterly & annually)

How has PROC PE Ratio performed in the past?

The mean historical PE Ratio of Procaps Group S.A. over the last ten years is -43.66. The current 4.86 PE Ratio has changed -1213.24% with respect to the historical average. Over the past ten years (40 quarters), PROC's PE Ratio was at its highest in in the June 2020 quarter at 28.08. The PE Ratio was at its lowest in in the June 2021 quarter at -438.52.

Procaps Group S.A. (PROC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Procaps Group S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Procaps Group S.A. (PROC) Average PE Ratio

How has PROC PE Ratio performed in the past?

The current PE Ratio of Procaps Group S.A. (PROC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Procaps Group S.A. (PROC) PE Ratio vs. Peers

How is PROC’s PE Ratio compared to its peers?

Procaps Group S.A.’s PE Ratio is less than Silver Spike Investment Corp. (0), greater than Sihuan Pharmaceutical Holdings Group Ltd. (0), greater than Phibro Animal Health Corporation (-149.93), less than Eagle Pharmaceuticals, Inc. (50.36), greater than Delta 9 Cannabis Inc. (0.19), greater than RAMM Pharma Corp. (-0.06), greater than City View Green Holdings Inc. (-0.20), greater than Craftport Cannabis Corp. (-0.89), greater than Speakeasy Cannabis Club Ltd. (-0.01), greater than Collegium Pharmaceutical, Inc. (-0.00), less than ANI Pharmaceuticals, Inc. (10.58), greater than Prestige Consumer Healthcare Inc. (-148.20), less than Regencell Bioscience Holdings Limited (18.97), greater than null (-13.79),

Build a custom stock screener for Procaps Group S.A. (PROC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Procaps Group S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Procaps Group S.A. (PROC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Procaps Group S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.